Drug intelligence / Profile preview

13C3 caffeine

Development stage
Unknown
Lead developer
Universität Greifswald
Modality
Small Molecules
Administration
Oral
01

Overview

13C3 caffeine is a stable isotope-labeled form of caffeine (1,3,7-trimethylxanthine) where three carbon atoms are replaced with the carbon-13 isotope. It is primarily utilized in clinical research as a metabolic probe or diagnostic marker to investigate physiological processes such as gastric emptying, intestinal absorption, and liver function. In the context of biopharmaceutical research at the Universität Greifswald, it is used as a reference marker to evaluate the performance of oral delivery systems, specifically to track the disintegration and absorption kinetics of enteric-coated and permeation-enhancing formulations for vitamins like cyanocobalamin (B12) and thiamine (B1). As a chemical entity, caffeine acts as a non-selective adenosine receptor antagonist and a competitive phosphodiesterase inhibitor, though its application in this specific trial context is for its pharmacokinetic properties as a tracer rather than for therapeutic effect.

Other names
1,3,7-trimethylxanthine-13C3[13C3]-caffeine
02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)ADORA2B (Adenosine A2B receptor)ADORA3 (Adenosine A3 receptor)PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on 13C3 caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 13C3 caffeine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call